Angeline K. Shashlo

Executive Officer at Cirius Therapeutics, Inc.

Angeline K. Shashlo

Angeline K. Shashlo

Executive Officer at Cirius Therapeutics, Inc.

Overview
RelSci Relationships

451

Relationships
RelSci Relationships are individuals Angeline K. Shashlo likely has professional access to. A relationship does not necessarily indicate a personal connection.

Co-Founder at Metabolic Solutions Development Co. LLC

Relationship likelihood: Strong

Co-Founder at Metabolic Solutions Development Co. LLC

Relationship likelihood: Strong

Chief Medical Officer at NephRx Corp.

Relationship likelihood: Strong

Manager at SWMF Life Science Fund GP LLC

Relationship likelihood: Strong

Chairman & Chief Executive Officer at Van Andel Institute

Relationship likelihood: Average

Former Chief Medical Officer at Tobira Therapeutics, Inc. (Inactive)

Relationship likelihood: Average

Chief Medical Officer at Cirius Therapeutics, Inc.

Relationship likelihood: Average

Co-Founder at Mavupharma, Inc.

Relationship likelihood: Average

Chief Executive Officer & Director at Cirius Therapeutics, Inc.

Relationship likelihood: Average

Chief Executive Officer at Metabolic Solutions Development Co. LLC

Relationship likelihood: Average

Paths to Angeline K. Shashlo
Potential Connections via
Relationship Science
You
Angeline K. Shashlo
Executive Officer at Cirius Therapeutics, Inc.
Education
Bachelor of Science Degree in Pharmacy

The University of Michigan (UM, U-M, UMich, or U of M), frequently referred to as simply Michigan, is a public research university located in Ann Arbor, Michigan, United States. It is the state's oldest university and the flagship campus of the University of Michigan. It is one of the original eight Public Ivy universities and is one of the founding members of the Association of American Universities. It has been ranked among the top five research universities in the US, and among the top 20 universities in the world. U-M also has satellite campuses in Flint and Dearborn.

Career History
Vice President-Development
2009 - Current

Metabolic Solutions Development Co. LLC operates as a drug discovery and development company. Its products include MSDC-0160 and MSDC-0602. The company was founded by Jerry R. Colca and Rolf Kletzien in 2006 and is headquartered in Kalamazoo, MI.

Executive Officer
Current

Cirius Therapeutics, Inc. operates as a biotechnology company. It offers metabolic treatment for nonalcoholic steatohepatitis. The company was founded by Jerry R. Colca and Brian Finck and is headquartered in San Diego, CA.

Senior Vice President
Prior - 2009

Genaera Corp. develops drugs for asthma, cancer, cystic fibrosis and age-related macular degeneration. It is a biopharmaceutical company committed to developing medicines for serious diseases from genomics and natural products. It's products include EVIZON, to treat ophthalmic indications, specifically age-related macular degeneration. Squalamine lactate, for the treatment of cancerous solid tumors. It's third product candidate, LOMUCIN to treat the overproduction of mucus secretions involved in chronic respiratory disease. Fourth product candidate, interleukin-9 antibody, is a respiratory treatment based on the discovery of a genetic cause of asthma. It also has a number of discovery research programs focused on the treatment of obesity, infectious diseases and inflammatory disorders. The company is headquartered in Plymouth Meeting, PA.

Transactions
Details Hidden

Cirius Therapeutics, Inc. raised money in a private placement transaction

Details Hidden

Metabolic Solutions Development Co. LLC raised money in a private placement transaction

Details Hidden

Metabolic Solutions Development Co. LLC raised money in a private placement transaction

Investments
Details Hidden

Tobira Therapeutics, Inc. operates as a clinical-stage biopharmaceutical company, which focuses on developing and commercializing of therapies to treat liver disease, HIV, fibrosis and inflammation. Its lead product candidate, cenicriviroc or CVC, is a proprietary immunomodulator that may be used to treat a number of diseases, including NASH, kidney fibrosis, HIV-1 and others. The company was founded by Eckard Weber in September 2006 and is headquartered in South San Francisco, CA.

This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Angeline K. Shashlo. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Angeline K. Shashlo's profile does not indicate a business or promotional relationship of any kind between RelSci and Angeline K. Shashlo.